Robert L. Sutherland

Active 1963–2025

Also published as
Robert L Sutherland
136
Papers
26,079
Citations
94
h-index
135
i10-index

Citations

Citations per year for Robert L. Sutherland1967: 1 citations1975: 1 citations1980: 3 citations1981: 3 citations1982: 3 citations1983: 17 citations1984: 22 citations1985: 17 citations1986: 15 citations1987: 21 citations1988: 27 citations1989: 43 citations1990: 17 citations1991: 25 citations1992: 15 citations1993: 25 citations1994: 45 citations1995: 41 citations1996: 35 citations1997: 70 citations1998: 102 citations1999: 95 citations2000: 107 citations2001: 115 citations2002: 118 citations2003: 180 citations2004: 218 citations2005: 237 citations2006: 233 citations2007: 194 citations2008: 182 citations2009: 174 citations2010: 214 citations2011: 250 citations2012: 246 citations2013: 231 citations2014: 237 citations2015: 202 citations2016: 201 citations2017: 259 citations2018: 245 citations2019: 752 citations2020: 820 citations2021: 802 citations2022: 573 citations2023: 357 citations2024: 522 citations2025: 254 citations2026: 6 citations1968–1974: no citations, so these years are not shown1976–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,310 citing papers, 29% of this breakdownChina: 1,234 citing papers, 10.8% of this breakdownUnited Kingdom: 766 citing papers, 6.7% of this breakdownGermany: 615 citing papers, 5.4% of this breakdownAustralia: 601 citing papers, 5.3% of this breakdownItaly: 493 citing papers, 4.3% of this breakdownCanada: 469 citing papers, 4.1% of this breakdownFrance: 389 citing papers, 3.4% of this breakdownJapan: 360 citing papers, 3.2% of this breakdownNetherlands: 258 citing papers, 2.3% of this breakdownSpain: 254 citing papers, 2.2% of this breakdownSouth Korea: 211 citing papers, 1.9% of this breakdown
0%29%Other 21.4%

Fields

  • Medicine49.1%
  • Biochemistry, Genetics and Molecular Biology42.6%
  • Immunology and Microbiology2.4%
  • Neuroscience1.8%
  • Nursing0.6%
  • Chemistry0.5%
  • Other3%

Topics

  • Pancreatic and Hepatic Oncology Research6%
  • Estrogen and related hormone effects4.2%
  • Cancer-related Molecular Pathways3.4%
  • Cancer Genomics and Diagnostics2.9%
  • Cancer Cells and Metastasis2.7%
  • Epigenetics and DNA Methylation2.7%
  • Other78.1%

Coauthors

All papers

Open in search
  1. Genomic analyses identify molecular subtypes of pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Darrin F. Taylor, Kelly Quek, Alan J. Robertson, Lorena Pantano, Laura Mincarelli, Luis Navarro-Sánchez, Lisa Evers, Jianmin Wu, Mark Pinese, Mark J. Cowley, Marc D. Jones, Emily K. Colvin, Adnan M. Nagrial, Emily S. Humphrey, Lorraine A. Chantrill, Amanda Mawson, Jeremy L. Humphris, Angela Chou, Marina Pajic, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Lovell, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Kim Moran‐Jones, Nigel B. Jamieson, Janet Graham, Fraser R. Duthie, Karin A. Oien, Jane Hair, Robert Grützmann, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Borislav C. Rusev, Paola Capelli, Roberto Salvia, Giampaolo Tortora, Debabrata Mukhopadhyay, Gloria M. Petersen, Australian Pancreatic Cancer Genome Initiative, Donna M. Munzy, William E. Fisher, Saadia A. Karim, James R. Eshleman, Ralph H. Hruban, Christian Pilarsky, Jennifer P. Morton, Owen J. Sansom, Aldo Scarpa, Elizabeth A. Musgrove, Ulla‐Maja Bailey, Oliver Hofmann, Robert L. Sutherland, David A. Wheeler, Anthony J. Gill, Richard A. Gibbs, John V. Pearson and 3 more - Nature 2016 cited by 3,775

  2. Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 cited by 390

  3. Cyclin D as a therapeutic target in cancer

    Authors: , , , , - Nature reviews. Cancer 2011 cited by 1,367

  4. Biological determinants of endocrine resistance in breast cancer

    Authors: , - Nature reviews. Cancer 2009 cited by 1,259

  5. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 501

  6. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susanna L. Cooke, Stephan B. Dreyer, Paul Grimwood, Shane Kelly, John L. Marshall, Brian McDade, Daniel L. McElroy, Donna Ramsay, Rosanna Upstill‐Goddard, Selma Rebus, Jane Hair, Nigel B. Jamieson, Colin J. McKay, Paul Westwood, Nicola Williams, Fraser R. Duthie, Andrew V. Biankin, Amber L. Johns, Amanda Mawson, David K. Chang, Christopher J. Scarlett, Mary-Anne L. Brancato, Sarah J. Rowe, Skye H. Simpson, Mona Martyn-Smith, Michelle T. Thomas, Lorraine A. Chantrill, Venessa Chin, Angela Chou, Mark J. Cowley, Jeremy L. Humphris, R. Scott Mead, Adnan Nagrial, Marina Pajic, Jessica Pettit, Mark Pinese, Ilse Rooman, Jianmin Wu, Tao Jiang, Renee DiPietro, Clare Watson, Angela Steinmann, Hong Ching Lee, Rachel Wong, Andreia V. Pinho, Marc Giry-Laterrière, Roger J. Daly, Elizabeth A. Musgrove, Robert L. Sutherland, Sean M. Grimmond, Nicola Waddell, Karin S. Kassahn, David K. Miller, Peter J. Wilson, Ann-Marie Patch, Sarah Song, Ivon Harliwong, Senel Idrisoglu, Ehsan Nourbakhsh, Suzanne Manning, Shivangi Wani, Milena Gongora, Matthew J. Anderson, Oliver Holmes, Conrad Leonard, Darrin F. Taylor, Scott Wood, Christina Xu, Kátia Nones, J. Lynn Fink and 105 more - Cell Reports 2020 cited by 127

  7. Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2009 cited by 398

  8. Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1

    Authors: , , , , , , , , , , , , , , - Nature 2014 cited by 161

  9. The Propeptide Mediates Formation of Stromal Stores of PROMIC-1: Role in Determining Prostate Cancer Outcome

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Research 2005 cited by 154

  10. Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

    Authors: , , , , , , , , , , , , , , - Molecular Cancer Therapeutics 2012 cited by 154

  11. A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Urology 2003 cited by 401

  12. National Trends in Colorectal Cancer Incidence Among Older and Younger Adults in Canada

    Authors: , , , , , , - JAMA Network Open 2019 cited by 121

  13. Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2

    Authors: , , , , - Journal of Biological Chemistry 1997 cited by 447

  14. Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 315

  15. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

    Authors: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 289

  16. Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers

    Authors: , , , , , , , , , , - Breast Cancer Research 2011 cited by 175

  17. Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2011 cited by 169

  18. TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers

    Authors: , , , , , , , , , , , , - Molecular and Cellular Biology 2012 cited by 93

  19. The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 92

  20. Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients

    Authors: , , , , , , , , , , , , , - Histopathology 2020 cited by 48

  21. Prolactin Controls Mammary Gland Development via Direct and Indirect Mechanisms

    Authors: , , , , , , , - Developmental Biology 1999 cited by 334

  22. PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality

    Authors: , , , , , , , , - International Journal of Cancer 2009 cited by 304

  23. An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2005 cited by 217

  24. EDD, the Human Hyperplastic Discs Protein, Has a Role in Progesterone Receptor Coactivation and Potential Involvement in DNA Damage Response

    Authors: , , , , , , , , , - Journal of Biological Chemistry 2002 cited by 104